A report from The Business Research Company on Robot-Assisted PCI Market underscores growth drivers, obstacles, and critical market dynamics
Expected to grow to $149.68 billion in 2030 at a compound annual growth rate (CAGR) of 40.2%”— The Business Research Company
"The robot-assisted percutaneous coronary intervention (PCI) market is undergoing swift transformation due to technological progress and the rising global incidence of cardiovascular conditions. This cutting-edge cardiology technique is reshaping the execution of intricate coronary procedures, offering enhanced precision and better patient protection. Below, we examine the market’s present scale, primary growth drivers, regional perspectives, and anticipated developments.
Market Size and Growth Trajectory of the Robot-Assisted Percutaneous Coronary Intervention Market
The robot-assisted percutaneous coronary intervention (PCI) market has recently experienced significant expansion. Projections indicate an increase from $27.56 billion in 2025 to $38.73 billion in 2026, reflecting a compound annual growth rate (CAGR) of 40.5%. This upswing is attributed to the growing prevalence of coronary artery disease, difficulties in achieving precision with manual PCI, expanded use of catheter-based interventions, heightened awareness of radiation risks, and the proliferation of cardiac catheterization labs.
Download a free sample of the robot-assisted percutaneous coronary intervention (pci) market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27408&type=smp&utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Aug_PR
Looking ahead, the robot-assisted PCI market is expected to sustain its rapid climb, reaching $149.68 billion by 2030 at a CAGR of 40.2%. Key contributors to this growth include advancements in robotic intervention technologies, the increasing adoption of automation in cardiology, heightened investment in digital healthcare infrastructure, and rising demand for complex PCI procedures. Moreover, positive regulatory approvals for robotic systems are facilitating broader uptake. Emerging trends encompass a shift toward minimally invasive cardiac procedures, a focus on reducing clinician radiation exposure, greater demand for procedural precision, expanded capabilities for complex coronary interventions, and improvements in patient safety and clinical outcomes.
Understanding Robot-Assisted Percutaneous Coronary Intervention (R-PCI) Technology
Robot-assisted percutaneous coronary intervention is a minimally invasive procedure where robotic systems assist in guiding catheters, balloons, and stents through narrowed or blocked coronary arteries. This technology delivers superior precision, stability, and control, lowering the likelihood of human error during the procedure. It also reduces radiation exposure for both patients and medical staff, boosting overall safety and efficiency while positively influencing clinical results.
View the full robot-assisted percutaneous coronary intervention (pci) market report:
https://www.thebusinessresearchcompany.com/report/robot-assisted-percutaneous-coronary-intervention-pci-global-market-report?utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Aug_PR
Factors Fueling Growth in the Robot-Assisted PCI Market
A major force propelling the robot-assisted PCI market forward is the escalating worldwide incidence of cardiovascular diseases. These conditions—including coronary artery disease, heart attacks, and strokes—stem largely from sedentary lifestyles, which contribute to obesity, hypertension, and poor heart health. Robot-assisted PCI effectively addresses these ailments by safely reopening blocked coronary arteries, restoring normal blood flow, and minimizing procedural risks and radiation exposure, thereby improving patient outcomes.
For instance, according to a December 2024 report by GOV.UK, approximately 2.24 million adults in England—around 4.4% of those aged 18 and above—were diagnosed with chronic kidney disease (CKD) as of March 2024. This represents an increase from 2.09 million cases the previous year, illustrating the broader rise in cardiovascular-related health issues that underpin demand for advanced interventions like robot-assisted PCI.
Regional Market Leadership and Growth Outlook
In 2025, North America accounted for the largest share of the robot-assisted percutaneous coronary intervention market. However, the Asia-Pacific region is expected to record the fastest growth over the forecast period. The market analysis covers key territories including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, offering a global perspective on emerging opportunities and regional developments.
What’s new in our 2026 market reports:
• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel dashboards
• Market hotspots infographics
• Key technologies and future trends
• Updated graphics and tables
Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: marketing@tbrc.info
The Business Research Company – www.thebusinessresearchcompany.com
Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company"
Oliver Guirdham
The Business Research Company
+44 7882 955267
info@tbrc.info
Visit us on social media:
LinkedIn
Facebook
X
